Back to Florida

SB0784 • 2026

Medicaid Coverage of Continuous Glucose Monitors

Medicaid Coverage of Continuous Glucose Monitors

Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Harrell
Last action
2026-03-13
Official status
Senate - Died in Health Policy
Effective date
Upon becom

Plain English Breakdown

The official source material does not provide details on what happens if federal approval is denied or how quickly changes will be implemented after receiving approval.

Medicaid Coverage for Glucose Monitors

This bill requires the Agency for Health Care Administration to seek federal permission within 30 days of passing this law, so that Medicaid can cover continuous glucose monitors and related supplies as a durable medical equipment benefit.

What This Bill Does

  • Requires the Agency for Health Care Administration to ask for federal approval through a Medicaid waiver or state plan amendment within 30 days after the bill becomes a law.
  • Allows Medicaid to provide coverage for continuous glucose monitors and related supplies if approved by the federal government as a durable medical equipment benefit.
  • Reimburses licensed durable medical equipment providers who supply these items, provided the claim is submitted through Medicare Healthcare Common Procedure Coding System.

Who It Names or Affects

  • Medicaid recipients who need continuous glucose monitors and related supplies
  • Licensed durable medical equipment providers

Terms To Know

Continuous Glucose Monitors (CGMs)
Devices that check blood sugar levels continuously, helping people with diabetes manage their condition.
Medicaid
A government program that helps low-income individuals pay for medical care.

Limits and Unknowns

  • The bill does not specify what happens if federal approval is denied.
  • It's unclear how quickly the agency will implement changes after receiving federal approval.

Bill History

  1. 2026-03-13 Senate

    • Died in Health Policy

  2. 2026-01-13 Senate

    • Introduced

  3. 2025-12-16 Senate

    • Referred to Health Policy; Appropriations Committee on Health and Human Services; Appropriations

  4. 2025-12-08 Senate

    • Filed

Official Summary Text

Medicaid Coverage of Continuous Glucose Monitors; Requiring the Agency for Health Care Administration, within a specified timeframe, to seek federal approval as needed to provide coverage of continuous glucose monitors and related supplies as a durable medical equipment benefit under the Medicaid program; providing for the reimbursement of such equipment, etc.

Current Bill Text

Read the full stored bill text
Florida Senate
-
2026

SB 784

By
Senator Harrell

31-00389-26 2026784__
1 A bill to be entitled
2 An act relating to Medicaid coverage of continuous
3 glucose monitors; requiring the Agency for Health Care
4 Administration, within a specified timeframe, to seek
5 federal approval as needed to provide coverage of
6 continuous glucose monitors and related supplies as a
7 durable medical equipment benefit under the Medicaid
8 program; providing for the reimbursement of such
9 equipment; providing construction; requiring the
10 agency to implement these changes upon receiving any
11 necessary federal approval; providing an effective
12 date.
13
14 Be It Enacted by the Legislature of the State of Florida:
15
16 Section 1.
(1)

Within 30 days after this act becomes a

17
law, t
he Agency for Health Care Administration shall seek

18
federal approval through a Medicaid waiver or state plan

19
amendment as needed to provide coverage of continuous glucose

20
monitors and related supplies as a durable medical equipment

21
benefit for Medicaid recipients. A licensed durable medical

22
equipment provider must be reimbursed for continuous glucose

23
monitors and related supplies, provided the claim is submitted

24
through
th
e Medicare Healthcare Common Procedure Coding System.

25
The agency may not require such provider to use a
National Drug

26
Code
number as part of such claim submission.

27
(2)

This section does not preclude the agency from

28
providing additional coverage of continuous glucose monitors as

29
a Medicaid pharmacy benefit.

30
(3)

The agency
shall
begin
implement
ation of
these changes

31
upon receiving any necessary federal approval
.

32 Section 2. This act shall take effect upon becoming a law.